Loss of systemic endothelial function post-PCI

Acute Cardiac Care

Volumn 10, Issue 2, 2008, Pages 79-87

  Han, Bo ^a   Ghanim, Diab ^a   Peleg, Aviva ^a   Uretzky, Gideon ^b   Hasin, Yonathan ^a  

^a BARUCH PADEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angioplasty; Contrast media; Endothelin; Endothelium; Natriuretic peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CORIN; ENDOTHELIN; NATRIURETIC FACTOR; NESIRITIDE; PRO BRAIN NATRIURETIC PEPTIDE; SODIUM CHLORIDE;

ADULT; ARTERY DILATATION; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRACHIAL ARTERY; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; VASODILATION;

EID: 45849138920     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940701802330     Document Type: Review

References (32)

1. Blum A, Schneider DJ, Sobel BE, Dauerman HL. Endothelial dysfunction and inflammation after percutaneous coronary intervention. Am J Card. 2004;94:1420-3.
2. Hojo Y, Ikeda U, Katsuki TA, Shimada K. Release of endothelin1 and angiotensin II induced by percutaneous transluminal coronary angioplasty. Catheterization and Cardiovasc Interv. 2000;51:41-9.
3. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol. 1992;3:58-65.
4. Dalby MCD, Davidson SJ , Burman JF, Clague J, Sigwart U, Davies SW. Systemic platelet effect of contrast media: implications for cardiologic research and clinical practice. Am Heart J. 2002;143.
5. Zhan X, Agrawal DK, Thorpe PE. Effect of iodinated contrast media on neutrophil adhesion to cultured endothelial cells. J Vasc Interv Radiol. 1998;9:808-16.
6. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation. 2005;111:70-5.
7. Kitta Y, Nakamura T, Kodama Y, Takano H, Umetani K, Fujioka D, et al. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol. 2005;46:648-55.
8. Kurz T, Schafer U, Dendorfer A, Hartmann F, Raasch W, Tolg R, et al. Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. Am J Cardiol. 2001;88:1351-7.
9. Lincoff AM, Kereiakes DJ, Mascelli MA, Deckelbaum LI, Barnathan ES, Patel KK, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation. 2001;104:163.
10. George J, Shmuel SB, Roth A, Herz I, Izraelov S, Deutsch V, et al. Arginine attenuates lymphocyte activation and antioxidized LDL antibody levels in patients undergoing angioplasty. Atherosclerosis. 2004;174:323-7.
11. Lee TM, Lin MS, Tsai CH, Chang NC. Effect of ischaemic preconditioning on regional release of inflammatory markers. Clin Sci. 2005;109:267-76.
12. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain B-type natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol. 2000;23:776-80.
13. Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest. 1991;87:1999-2004.
14. Yoshizumi M, Tsuji H, Nishimura H, Masuda H, Kunieda Y, Kawano H, et al. Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells. Thromb Haemost. 1999;82:1497-503.
15. Celermajer DS, Sorensen KE, Gooch V M, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-5.
16. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-9.
17. Gorski TP, Campbell DJ. Angiotensin-converting enzyme determination in plasma during therapy with converting enzyme inhibitor: two methods compared. Clin Chem. 1991;37:1390-3.
18. Chien Tzu-I, Chen Hui-hou, Kao Jau-Tsuen. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP. Clin Chim Acta 2006;369:95.
19. Win Yan, Fage Wu, Morser J, Zingyu Wu. Corin, a transmembrane cardiac serine protease, acts as a natriuretic peptide converting enzyme. Proc Natl Acad Sci. 2000; :8525-9.
20. Ahluwalia A, MacAllister RJ, Hobbs AJ. Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic Res Cardiol. 2004;99:83-9.
21. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 2004;44:733-9.
22. Blum A, Schneider DJ, Sobel BE, Dauerman HL. Endothelial dysfunction and inflammation after percutaneous coronary intervention. Am J Cardiol. 2004;94:1420-3.
23. Vaziri ND, Wang XQ. cGMP-Mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension 1999;:1237-41.
24. Gori T, Burstein JM, Ahmed S, Miner SE, Al-Hesayen A, Kelly S, et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: A human in vivo study. Circulation. 2001;140:1119-23.
25. Li H, Wallerath T, Munzel T, Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in respect to drugs. Nitric Oxide Biol Chem. 2002;7:149-64.
26. Goetze JP, Yongzhong W, Rehfeld JF, Jorgensen E, Kastrup J. Coronary angiography transiently increases plasma pro-B-type natriuretic peptide. Eur Heart J. 2004;25:759-64.
27. Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res. 1991;69:491-500.
28. Bordenave L, Georges A, Bareille R, Conrad V, Villars F, Amedee J. Human bone marrow endothelial cells: a new identified source of B-type natriuretic peptide. Peptides. 2002;23:935-40.
29. Suzuki E, Hirata Y, Kohmoto O, Sugimoto T, Hayakawa H, Matsuoka H, et al. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res. 1992;71:1039-48.
30. Gelfand RA, Frank HJ, Levin E, Pedram A. Brain and atrial natriuretic peptides bind to common receptors in brain capillary endothelial cells. Am J Physiol. 1991;261:E183-9.
31. Emori T, Hirata Y, Imai T, Eguchi S, Kanno K, Marumo F. Cellular mechanisms of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology. 1993;133:2474-80.
32. Murohara T, Kugiyama K, Ota Y, Doi H, Ogata N, Ohgushi M, et al. Effects of atrial and brain natriuretic peptides on lysophosphatidylcholine-mediated endothelial dysfunction. J Cardiovasc Pharmacol. 1999;34:870-8.